(Q34107813)

31 July 2017

1 reference

title

Second-line chemotherapy for non-small-cell lung cancer (English)

1 reference

31 July 2017

0 references

1 reference

F V Fossella

1

1 reference

31 July 2017

publication date

1 January 2000

1 reference

31 July 2017

published in

Current Oncology Reports

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

96-101

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-000-0016-x

31 July 2017

exact match

0 references

cites work

Phase II studies of gemcitabine for non-small cell lung cancer in Japan.

1 reference

12 December 2020

Phase I and pharmacologic study of topotecan: a novel topoisomerase I inhibitor

1 reference

12 December 2020

Is chemotherapy for metastatic non-small cell lung cancer "worth it"?

1 reference

12 December 2020

An early phase II study of CPT-11 in primary lung cancer

1 reference

12 December 2020

Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?

1 reference

12 December 2020

Phase II study of docetaxel for advanced or metastatic platinum-refractory non-small-cell lung cancer

1 reference

12 December 2020

Counting the costs of chemotherapy in a National Cancer Institute of Canada randomized trial in nonsmall-cell lung cancer

1 reference

12 December 2020

Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial

1 reference

12 December 2020

Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients

1 reference

12 December 2020

Second-line chemotherapy with 96-hour infusional paclitaxel in refractory non-small cell lung cancer: report of a phase II trial.

1 reference

12 December 2020

Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group

1 reference

12 December 2020

Paclitaxel by 1-hour infusion: an active drug in metastatic non-small-cell lung cancer

1 reference

12 December 2020

A phase II study of CPT-11, a camptothecin derivative, in patients with primary lung cancer. CPT-11 Cooperative Study Group

1 reference

12 December 2020

10.1007/S11912-000-0016-X

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1053679736

0 references

1 reference